# A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults

> **NCT07385248** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Addpharma Inc.** · enrollment: 28 (estimated)

## Conditions studied

- Gastritis

## Interventions

- **DRUG:** AD-229
- **DRUG:** AD-2291

## Key facts

- **NCT ID:** NCT07385248
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385248, "A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07385248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*